Get started
Author

Cristina Trevino‐Peinado

Observed names: C. Trevino-Peinado, C. Treviño Peinado, Cristina Trevino-Peinado, Cristina Treviño, Cristina Treviño Peinado, Trevino Peinado, Cristina
ORCID: 0000-0001-8711-4884
Observed ORCID: 0000-0001-8711-4884
OpenAlex ID: A5047453810
Is cardiac function impaired in premotor Parkinson's disease? A retrospective cohort study
2013 · Jose‐Alberto Palma, Maria‐Mar Carmona‐Abellan, et al. · Movement Disorders · 81
Machine‐learning‐based approach for predicting response to anti‐calcitonin gene‐related peptide ( CGRP) receptor or ligand antibody treatment in patients with migraine: A multicenter Spanish study
2022 · Alicia Gonzalez‐Martinez, Josué Pagán, et al. · European Journal of Neurology · 51
PDF
Monitoring the Effect of Immunotherapy in Autoimmune Limbic Encephalitis Using 18F-FDG PET
2015 · Cristina Trevino-Peinado, Javier Arbizu, et al. · Clinical Nuclear Medicine · 22
Effectiveness, tolerability, and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study
2023 · Alicia Gonzalez-Martinez, Ancor Sanz-García, et al. · Pain Medicine · 12
PDF
Concomitant anti-CGRP and immunomodulatory treatments in patients with migraine: towards integrated management strategies
2025 · María Clara García-Castillo, Álvaro Sierra-Mencía, et al. · Journal of Neurology · 8
PDF
Subcortical Microbleeds in Disseminated Intravascular Coagulation Mimicking Amyloid Angiopathy
2015 · Cristina Trevino‐Peinado, José Luis Zubieta, et al. · Journal of Neuroimaging · 5
Evaluation of the effectiveness and safety of anti‐CGRP monoclonal antibodies in patients with migraine and autoimmune diseases: IMMUNO ‐ CGRP study
2026 · María Clara García‐Castillo, Álvaro Sierra‐Mencía, et al. · Headache The Journal of Head and Face Pain · 4
Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti‐calcitonin gene‐related peptide therapies: The PREVENAC study
2024 · Ana Beatriz Gago‐Veiga, Noelia Lopez‐Alcaide, et al. · European Journal of Neurology · 4
PDF
Consenso sobre anticuerpos monoclonales en migraña del Grupo de Estudio de Cefaleas de la Asociación Madrileña de Neurología
2023 · Alba Cárcamo Fonfría, Álex Jaimes Sánchez, et al. · Kranion · 2
PDF
ESTELA‐Study: Long‐Term Effectiveness and Safety of Anti‐Calcitonin Gene‐Related Peptide Monoclonal Antibodies in Real‐World Clinical Practice
2026 · Alba Somovilla, Iris Fernández‐Lázaro, et al. · Brain and Behavior
Calidad de vida con rimegepant y atogepant en migraña: evaluación mediante escalas a 3 y 6 meses
2026 · Sofía García Martínez, Irene Morona Mínguez, et al. · Sociedad Española de Farmacia Hospitalaria eBooks
An expanding threat; a case of encephalitis caused by West Nile Virus in the Madrid Region (Spain)
2025 · Víctor Antón Berenguer, Sara Gómez de Frutos, et al. · Diagnostic Microbiology and Infectious Disease
21117. Tratamiento Con Catéter Intraventricular Ommaya Y Olaparib En Paciente Joven Con Carcinomatosis Leptomeníngea Y Mutación En Brca1
2024 · C. Treviño Peinado, M. Echarri González, et al. · Neurology Perspectives
Validación externa del modelo predictivo de respuesta a anticuerpos monoclonales anti-CGRP en pacientes con migraña crónica y episódica
2023 · Sánchez Rodríguez, Carmen, Gago Veiga, Ana Beatriz, et al. · Hispana
Multicentre Real-World Case-Control Study of Effectiveness, Tolerability, and Anti-Calcitonin Gene-Related Peptide Response Predictors in the Elderly
2023 · Alicia Gonzalez-Martinez, Ancor Sanz-García, et al. · EMJ Neurology
Aspiración de cuerpos extraños ¿Un hallazgo ocasional en pacientes con demencia?
2013 · C. Trevino-Peinado, M. Paramo, et al. · Revista Clínica Española
Works count: 16
Citation count: 189
H-index: 5
I10-index: 4
Year
Topic
Type